查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1927672

全球感染疾病診斷劑市場：按產品類型、技術、疾病類型、應用、最終用戶、國家和地區分類的行業分析、市場規模、佔有率和2025-2032年預測

Diagnostic Reagents for Infectious Diseases Market, By Product Type, By Technology, By Disease Type, By Application, By End-User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 356 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到 2024 年，感染疾病診斷劑市場規模將達到 33.1531 億美元，從 2025 年到 2032 年，複合年成長率將達到 9.23%。

感染疾病診斷劑是用於檢測病原體的重要生化試劑，其作用在於準確識別細菌、病毒、真菌和寄生蟲。感染疾病的日益普及以及醫院和檢查室對早期準確診斷需求的不斷成長，正在推動市場成長。開發與快速、自動化和照護現場診斷平台相容的高靈敏度試劑具有重要意義，使其在疫情管理和分散式檢查中發揮關鍵作用。分子診斷和免疫檢測分析試劑的進步是值得關注的趨勢，這些進步能夠加快檢測速度並提高特異性。然而，試劑穩定性有限、依賴低溫運輸以及對不同病原體的性能差異等挑戰，限制了其在資源匱乏環境中的應用以及長期儲備以應對突發事件。

感染疾病診斷劑市場動態

感染疾病傳播日益加劇，對診斷測試的需求不斷增加

包括呼吸道感染疾病、結核病、愛滋病和新發病毒感染疾病在內的感染疾病日益流行，顯著推動了對感染疾病診斷劑，這些試劑對於準確快速地檢測疾病至關重要。隨著醫療系統日益重視早期診斷和有效的疾病管理，實驗室和醫院需要高品質的試劑，以確保在不同診斷平台上的敏感度、特異性和可重複性。診斷劑在分子診斷、免疫檢測和快速診斷測試中發揮至關重要的作用，它們能夠實現病原體鑑定、抗原-抗體反應和核酸擴增。向快速和照護現場診斷的轉變進一步增加了對能夠在緊湊型自動化系統中提供穩定性能的試劑的需求。此外，不斷擴大的疾病監測計畫和常規篩檢措施也在加速試劑的消耗。例如，近年來，國家公共衛生措施顯著增加了感染疾病診斷檢測的數量。此外，診斷檢測在預防保健、醫院感染控制和感染疾病應變的廣泛應用，也持續推動醫療機構對可靠、高效能診斷劑的需求。

感染疾病診斷劑市場：細分分析

全球感染疾病診斷劑市場按產品類型、技術、疾病類型、應用、最終用戶和地區進行細分。

依產品類型，市場區隔可分為四大類：分子診斷劑、免疫檢測試劑、臨床化學試劑、血液學試劑。在感染疾病診斷劑市場中，分子診斷劑佔據主導地位。這主要歸功於其在檢測病原體DNA或RNA方面的高靈敏度和特異性，使其成為快速且準確地診斷病毒和細菌性行為感染的關鍵。免疫檢測試劑位居第二，因其可靠性、擴充性和從照護現場檢測到檢查室環境的廣泛適用性，被廣泛應用於基於抗原-抗體的檢測。臨床化學試劑緊隨其後，支持生物標記監測和疾病進展追蹤等輔助檢測，是感染疾病初級診斷的補充。血液學試劑的市佔率雖小但不可忽視，尤其是在醫院檢查室，它們用於血球分析和感染控制中的免疫反應監測。總體而言，市場優先考慮因素反映了臨床效用、技術複雜性以及對快速、高效能診斷解決方案的需求。

根據技術類型，市場可分為四個細分領域：PCR/RT-PCR、ELISA、螢光和次世代定序(NGS)。在各種技術類型中，PCR/RT-PCR 在感染疾病診斷劑市場佔據主導地位。這得歸功於其廣泛的應用、高靈敏度以及基於核酸檢測的快速病原體檢測能力，使其成為分子診斷的黃金標準。 ELISA 位居第二，以其穩健性、易操作性和對多種感染疾病抗原和抗體檢測的適用性而聞名。螢光能夠精確地可視化和檢測病原體，尤其適用於專業檢查室應用，但需要更高級的技術知識。次世代定序(NGS) 已成為一項極具潛力的病原體全面分析和疫情追蹤技術，但其高成本和基礎設施要求限制了其應用。總體而言，技術優先級反映了臨床診斷中靈敏度、易用性和擴充性。

感染疾病診斷劑市場－區域分析

北美地區在感染疾病診斷劑市場主導，擁有最大的市場佔有率。這主要得益於其完善的醫療保健基礎設施、大量的研發投入以及先進分子診斷和免疫檢測試劑的廣泛應用，這些因素共同推動了臨床和檢查室對試劑的需求。美國引領區域成長，這得益於政府的篩檢計畫和私部門的積極參與。歐洲位居第二，德國、法國和英國等國家重視疾病的早期檢測和高品質試劑的使用，並透過公私夥伴關係擴大檢測能力。亞太地區正崛起為成長最快的市場，這主要歸功於醫療保健支出的成長、實驗室基礎設施的擴張以及感染疾病流行率的上升，尤其是在中國、印度和日本。這些因素推動了當地試劑的使用和生產。策略發展包括：生物梅里埃公司於2025年6月收購DayZero Diagnostics，以擴展其試劑產品組合；以及希森美康和凱傑公司於2025年10月在日本建立試劑供應和分銷合作夥伴關係。

感染疾病診斷劑市場—國家分析

從國家層級來看，美國在感染疾病診斷劑市場佔據主導地位，這得益於其先進的醫療基礎設施、分子檢測的廣泛應用以及公共和私營部門在疾病早期檢測方面的大量投資。德國、英國和法國等西歐國家緊隨其後，這得益於不斷擴大的檢測網路以及試劑在臨床診斷和公共衛生篩檢計畫中的高效利用。在亞太地區，由於醫療保健支出不斷成長、感染疾病率上升以及為減少進口依賴、提高試劑可及性並降低成本而採取的試劑供應鏈本地化舉措，中國和印度的試劑市場正在迅速擴張。

策略性措施包括：生物梅里埃於 2025 年 6 月收購 Day Zero Diagnostics，擴大其感染疾病試劑產品組合和次世代定序(NGS) 能力；以及 Sysmex 於 2025 年 10 月與 QIAGEN 合作，開始在日本銷售感染疾病試劑和診斷產品。

目錄

第1章感染疾病診斷劑市場概述

  • 分析範圍
  • 市場估算期

第2章執行摘要

  • 市場區隔
  • 競爭考察

第3章：感染疾病診斷劑的主要市場趨勢

  • 市場促進因素
  • 市場限制
  • 市場機遇
  • 未來市場趨勢

第4章感染疾病診斷劑市場：產業分析

  • PEST分析
  • 波特五力分析
  • 市場成長展望：概覽
  • 管理體制分析

第5章感染疾病診斷劑市場：地緣政治緊張局勢加劇的影響

  • 新冠疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章感染疾病診斷劑的市場狀況

  • 感染疾病診斷劑市佔率分析（2024 年）
  • 主要製造商的細分數據
    • 對現有公司的分析
    • 新興企業分析

第7章 依產品類型分類的感染疾病診斷劑市場

  • 概述
    • 細分市場佔有率分析：依產品類型
    • 分子診斷劑
    • 免疫檢測試劑
    • 臨床化學試劑
    • 血液學試劑

第8章 按技術分類的感染疾病診斷劑市場

  • 概述
    • 細分市場佔有率分析：依技術分類
    • PCR和RT-PCR
    • ELISA
    • 螢光
    • 次世代定序

第9章 依疾病類型分類的感染疾病診斷劑市場

  • 概述
    • 細分市場佔有率分析：依疾病類型分類
    • 病毒感染疾病
    • 細菌感染疾病
    • 黴菌感染疾病
    • 寄生蟲感染疾病

第10章 依應用分類的感染疾病診斷劑市場

  • 概述
    • 細分市場佔有率分析：按應用
    • 疾病診斷
    • 血液篩檢
    • 流行病學調查

第11章感染疾病診斷劑市場（依最終用戶分類）

  • 概述
    • 細分市場佔有率分析：依最終用戶分類
    • 醫院
    • 診斷檢查室
    • 血庫
    • 研究所

第12章 各地區感染疾病診斷劑市場

  • 介紹
  • 北美洲
    • 概述
    • 北美主要製造商
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲主要製造商
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 其他
  • 亞太地區
    • 概述
    • 亞太地區主要製造商
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 其他
  • 拉丁美洲
    • 概述
    • 拉丁美洲主要製造商
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 其他
  • 中東和非洲
    • 概述
    • 中東和非洲的主要製造商
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • 其他

第13章 主要供應商分析：感染疾病診斷劑產業

  • 競爭對手儀錶板
    • 競爭基準
    • 競爭定位
  • 公司簡介
    • Abbott Laboratories
    • Agilent Technologies
    • Beckman Coulter
    • Becton, Dickinson and Company
    • Bio-Rad Laboratories
    • Danaher Corporation
    • DiaSorin
    • Fujirebio
    • Grifols
    • Hologic
    • Merck KGaA
    • Ortho Clinical Diagnostics
    • QIAGEN
    • QuidelOrtho
    • Randox Laboratories
    • Roche Diagnostics
    • Sekisui Diagnostics
    • Siemens Healthineers
    • Sysmex Corporation
    • Thermo Fisher Scientific
    • Others

第14章 AnalystView 360度分析

簡介目錄
Product Code: ANV5958

The Diagnostic Reagents for Infectious Diseases Market size was valued at US$ 3,315.31 Million in 2024, expanding at a CAGR of 9.23% from 2025 to 2032.

Diagnostic reagents for infectious diseases are essential biochemical substances used to detect pathogens by enabling accurate identification of bacteria, viruses, fungi, and parasites. The growing prevalence of infectious diseases and rising demand for early and precise diagnosis across hospitals and laboratories are driving market growth. Opportunities exist in developing high-sensitivity reagents compatible with rapid, automated, and point-of-care diagnostic platforms, which are critical for outbreak management and decentralized testing. A prominent trend is the advancement of molecular and immunoassay-based reagents that offer faster turnaround times and improved specificity. However, challenges such as limited reagent stability, cold-chain dependency, and variability in performance across different pathogens restrict adoption in resource-limited settings and long-term stockpiling for emergency preparedness.

Diagnostic Reagents for Infectious Diseases Market- Market Dynamics

Increasing prevalence of infectious diseases and expanding diagnostic testing

The rising prevalence of infectious diseases such as respiratory infections, tuberculosis, HIV, and emerging viral outbreaks is significantly driving demand for diagnostic reagents for infectious diseases, which are critical for accurate and timely disease detection. As healthcare systems increasingly prioritize early diagnosis and effective disease management, laboratories and hospitals require high-quality reagents that ensure sensitivity, specificity, and reproducibility across diagnostic platforms. Diagnostic reagents play a vital role in molecular, immunoassay, and rapid diagnostic tests by enabling pathogen identification, antigen-antibody reactions, and nucleic acid amplification. The growing shift toward rapid and point-of-care diagnostics further increases demand for reagents that deliver consistent performance in compact and automated systems. Moreover, expanding disease surveillance programs and routine screening initiatives are accelerating reagent consumption. For instance, national public health initiatives have significantly increased diagnostic testing volumes for infectious diseases in recent years. Additionally, the growing use of diagnostic testing in preventive healthcare, hospital infection control, and outbreak preparedness continues to drive the need for reliable, high-performance diagnostic reagents across healthcare settings.

Diagnostic Reagents for Infectious Diseases Market- Segmentation Analysis:

The Global Diagnostic Reagents for Infectious Diseases Market is segmented on the basis of Product Type, Technology, Disease Type, Application, End-User, and Region.

The market is segmented into four categories based on product type: molecular diagnostic reagents, immunoassay reagents, clinical chemistry reagents, and hematology reagents. Among product types, Molecular Diagnostic Reagents hold the highest priority in the diagnostic reagents for infectious diseases market, driven by their high sensitivity and specificity for detecting pathogen DNA or RNA, making them essential for rapid and accurate diagnosis of viral and bacterial infections. Immunoassay Reagents rank second, widely used in antigen-antibody-based testing due to their reliability, scalability, and applicability across point-of-care and laboratory settings. Clinical Chemistry Reagents follow, supporting supportive testing such as monitoring biomarkers and disease progression, which complements primary infectious disease diagnostics. Hematology Reagents hold a smaller yet significant share, as they are used for blood cell analysis and immune response monitoring in infection management, particularly in hospital laboratories. Overall, market prioritization reflects clinical utility, technological complexity, and demand for rapid, high-performance diagnostic solutions.

The market is categorized into four segments based on technology: PCR & RT-PCR, ELISA, immunofluorescence, and next-generation sequencing (NGS). Among technology types, PCR & RT-PCR hold the highest priority in the diagnostic reagents for infectious diseases market due to their widespread adoption, high sensitivity, and ability to provide rapid nucleic acid-based detection of pathogens, making them the gold standard for molecular diagnostics. ELISA ranks second, valued for its robustness, ease of use, and applicability in detecting antigens and antibodies across a wide range of infectious diseases in both laboratory and point-of-care settings. Immunofluorescence follows, offering precise visualization and detection of pathogens, particularly in specialized laboratory applications, though it requires more technical expertise. Next-Generation Sequencing (NGS) ranks next, emerging as a high-potential technology for comprehensive pathogen profiling and outbreak tracking, yet its adoption is limited by higher costs and infrastructure requirements. Overall, prioritization reflects sensitivity, usability, and scalability in clinical diagnostics.

Diagnostic Reagents for Infectious Diseases Market- Geographical Insights

North America dominates the diagnostic reagents for infectious diseases market, accounting for the largest revenue share, as robust healthcare infrastructure, significant R&D investment, and high adoption of advanced molecular and immunoassay reagents drive demand across clinical and laboratory settings. The United States leads regional growth, supported by government screening programs and strong private sector participation. Europe holds the second-largest share, with countries such as Germany, France, and the UK emphasizing early disease detection and high-quality reagent adoption, bolstered by public-private partnerships that expand testing capacity. The Asia-Pacific region is emerging as the fastest-growing market due to increased healthcare spending, expanded lab infrastructure, and rising infectious disease prevalence, particularly in China, India, and Japan, encouraging local reagent use and production. Strategic developments include bioMerieux's acquisition of Day Zero Diagnostics in June 2025 to expand reagent portfolios and an October 2025 partnership between Sysmex and QIAGEN for reagent supply and distribution in Japan.

Diagnostic Reagents for Infectious Diseases Market- Country Insights

At the country level, the United States commands a leading position in the diagnostic reagents for infectious diseases market, propelled by advanced healthcare infrastructure, robust molecular testing adoption, and significant public and private investment in early disease detection. Western European countries such as Germany, the United Kingdom, and France follow closely, supported by expanding laboratory networks and strong reagent utilization in both clinical diagnostics and public health screening programs. In the Asia-Pacific region, China and India are rapidly expanding reagent markets due to increased healthcare spending, rising infectious disease prevalence, and initiatives to localize reagent supply chains to reduce dependence on imports, enhancing regional accessibility and reducing costs.

Strategic developments include bioMerieux's acquisition of Day Zero Diagnostics in June 2025 to broaden its infectious disease reagent portfolio and NGS capabilities, and Sysmex's collaboration with QIAGEN in October 2025 to distribute infectious disease reagents and diagnostic products in Japan.

Diagnostic Reagents for Infectious Diseases Market- Competitive Landscape:

The competitive landscape of the diagnostic reagents for infectious diseases market is moderately consolidated, with established players such as bioMerieux SA, QIAGEN, F. Hoffmann-La Roche Ltd., Abbott Laboratories, Thermo Fisher Scientific Inc., Danaher Corporation, and Sysmex Corporation leading through extensive reagent portfolios, global distribution networks, and ongoing innovation in molecular and immunoassay technologies. Continuous investment in R&D, reagent sensitivity, and automation capabilities differentiates market leaders while fostering competition. Mergers and acquisitions are shaping market dynamics; for example, bioMerieux's acquisition of Day Zero Diagnostics in June 2025 expanded its infectious disease reagent offerings and next-generation sequencing workflows. Strategic collaborations also strengthen competitive positioning, such as the Sysmex partnership with QIAGEN in October 2025 for exclusive distribution of infectious disease reagents and diagnostic products in Japan. Smaller firms focus on niche reagent solutions to capture specialized segments, balancing the innovation ecosystem.

Recent Developments:

In January 2024, QIAGEN launched two new QIAstat-Dx syndromic test panels in India-the Gastrointestinal Panel 2 and the Meningitis/Encephalitis Panel-joining the existing Respiratory SARS-CoV-2 Panel to enable rapid, accurate, multiplex infectious disease diagnosis using real-time PCR and single-use cartridges.

In July 2025, Microbix Biosystems launched its QUANTDx(TM) characterized reference materials, a new product line of accurately quantified and fully traceable reference materials covering more than 80 panels for infectious disease assay development and validation, aimed at improving diagnostic assay performance and regulatory readiness.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL DIAGNOSTIC REAGENTS FOR INFECTIOUS DISEASES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Abbott Laboratories
  • Agilent Technologies
  • Beckman Coulter
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories
  • Danaher Corporation
  • DiaSorin
  • Fujirebio
  • Grifols
  • Hologic
  • Merck KGaA
  • Ortho Clinical Diagnostics
  • QIAGEN
  • QuidelOrtho
  • Randox Laboratories
  • Roche Diagnostics
  • Sekisui Diagnostics
  • Siemens Healthineers
  • Sysmex Corporation
  • Thermo Fisher Scientific
  • Others

GLOBAL DIAGNOSTIC REAGENTS FOR INFECTIOUS DISEASES MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Molecular Diagnostic Reagents
  • Immunoassay Reagents
  • Clinical Chemistry Reagents
  • Hematology Reagents

GLOBAL DIAGNOSTIC REAGENTS FOR INFECTIOUS DISEASES MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • PCR & RT-PCR
  • ELISA
  • Immunofluorescence
  • Next-Generation Sequencing

GLOBAL DIAGNOSTIC REAGENTS FOR INFECTIOUS DISEASES MARKET, BY DISEASE TYPE- MARKET ANALYSIS, 2019 - 2032

  • Viral Infections
  • Bacterial Infections
  • Fungal Infections
  • Parasitic Infections

GLOBAL DIAGNOSTIC REAGENTS FOR INFECTIOUS DISEASES MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Disease Diagnosis
  • Blood Screening
  • Epidemiological Surveillance

GLOBAL DIAGNOSTIC REAGENTS FOR INFECTIOUS DISEASES MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Diagnostic Laboratories
  • Blood Banks
  • Research Institutes

GLOBAL DIAGNOSTIC REAGENTS FOR INFECTIOUS DISEASES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Diagnostic Reagents for Infectious Diseases Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Diagnostic Reagents for Infectious Diseases Market Snippet by Product Type
    • 2.1.2. Diagnostic Reagents for Infectious Diseases Market Snippet by Technology
    • 2.1.3. Diagnostic Reagents for Infectious Diseases Market Snippet by Disease Type
    • 2.1.4. Diagnostic Reagents for Infectious Diseases Market Snippet by Application
    • 2.1.5. Diagnostic Reagents for Infectious Diseases Market Snippet by End-User
    • 2.1.6. Diagnostic Reagents for Infectious Diseases Market Snippet by Country
    • 2.1.7. Diagnostic Reagents for Infectious Diseases Market Snippet by Region
  • 2.2. Competitive Insights

3. Diagnostic Reagents for Infectious Diseases Key Market Trends

  • 3.1. Diagnostic Reagents for Infectious Diseases Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Diagnostic Reagents for Infectious Diseases Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Diagnostic Reagents for Infectious Diseases Market Opportunities
  • 3.4. Diagnostic Reagents for Infectious Diseases Market Future Trends

4. Diagnostic Reagents for Infectious Diseases Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Diagnostic Reagents for Infectious Diseases Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Diagnostic Reagents for Infectious Diseases Market Landscape

  • 6.1. Diagnostic Reagents for Infectious Diseases Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Diagnostic Reagents for Infectious Diseases Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
    • 7.1.2. Molecular Diagnostic Reagents
    • 7.1.3. Immunoassay Reagents
    • 7.1.4. Clinical Chemistry Reagents
    • 7.1.5. Hematology Reagents

8. Diagnostic Reagents for Infectious Diseases Market - By Technology

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
    • 8.1.2. PCR & RT-PCR
    • 8.1.3. ELISA
    • 8.1.4. Immunofluorescence
    • 8.1.5. Next-Generation Sequencing

9. Diagnostic Reagents for Infectious Diseases Market - By Disease Type

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Disease Type, 2024 & 2032 (%)
    • 9.1.2. Viral Infections
    • 9.1.3. Bacterial Infections
    • 9.1.4. Fungal Infections
    • 9.1.5. Parasitic Infections

10. Diagnostic Reagents for Infectious Diseases Market - By Application

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 10.1.2. Disease Diagnosis
    • 10.1.3. Blood Screening
    • 10.1.4. Epidemiological Surveillance

11. Diagnostic Reagents for Infectious Diseases Market - By End-User

  • 11.1. Overview
    • 11.1.1. Segment Share Analysis, By End-User, 2024 & 2032 (%)
    • 11.1.2. Hospitals
    • 11.1.3. Diagnostic Laboratories
    • 11.1.4. Blood Banks
    • 11.1.5. Research Institutes

12. Diagnostic Reagents for Infectious Diseases Market- By Geography

  • 12.1. Introduction
    • 12.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 12.2. North America
    • 12.2.1. Overview
    • 12.2.2. Diagnostic Reagents for Infectious Diseases Key Manufacturers in North America
    • 12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.2.5. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.2.6. North America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 12.2.7. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.2.8. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 12.2.9. U.S.
      • 12.2.9.1. Overview
      • 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.9.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.2.9.4. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.2.9.5. U.S. Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 12.2.9.6. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.2.9.7. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 12.2.10. Canada
      • 12.2.10.1. Overview
      • 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.10.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.2.10.4. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.2.10.5. Canada Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 12.2.10.6. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.2.10.7. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 12.3. Europe
    • 12.3.1. Overview
    • 12.3.2. Diagnostic Reagents for Infectious Diseases Key Manufacturers in Europe
    • 12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.3.5. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.3.6. Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 12.3.7. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.3.8. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 12.3.9. Germany
      • 12.3.9.1. Overview
      • 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.9.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.9.4. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.9.5. Germany Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 12.3.9.6. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.9.7. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 12.3.10. UK
      • 12.3.10.1. Overview
      • 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.10.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.10.4. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.10.5. UK Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 12.3.10.6. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.10.7. UK Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 12.3.11. France
      • 12.3.11.1. Overview
      • 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.11.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.11.4. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.11.5. France Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 12.3.11.6. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.11.7. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 12.3.12. Italy
      • 12.3.12.1. Overview
      • 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.12.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.12.4. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.12.5. Italy Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 12.3.12.6. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.12.7. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 12.3.13. Spain
      • 12.3.13.1. Overview
      • 12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.13.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.13.4. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.13.5. Spain Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 12.3.13.6. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.13.7. Spain Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 12.3.14. The Netherlands
      • 12.3.14.1. Overview
      • 12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.14.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.14.4. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.14.5. The Netherlands Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 12.3.14.6. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.14.7. The Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 12.3.15. Sweden
      • 12.3.15.1. Overview
      • 12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.15.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.15.4. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.15.5. Sweden Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 12.3.15.6. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.15.7. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 12.3.16. Russia
      • 12.3.16.1. Overview
      • 12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.16.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.16.4. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.16.5. Russia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 12.3.16.6. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.16.7. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 12.3.17. Poland
      • 12.3.17.1. Overview
      • 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.17.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.17.4. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.17.5. Poland Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 12.3.17.6. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.17.7. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 12.3.18. Rest of Europe
      • 12.3.18.1. Overview
      • 12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.18.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.18.4. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.18.5. Rest of the Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 12.3.18.6. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.18.7. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 12.4. Asia Pacific (APAC)
    • 12.4.1. Overview
    • 12.4.2. Diagnostic Reagents for Infectious Diseases Key Manufacturers in Asia Pacific
    • 12.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.4.5. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.4.6. APAC Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 12.4.7. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.4.8. APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 12.4.9. China
      • 12.4.9.1. Overview
      • 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.9.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.9.4. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.9.5. China Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 12.4.9.6. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.9.7. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 12.4.10. India
      • 12.4.10.1. Overview
      • 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.10.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.10.4. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.10.5. India Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 12.4.10.6. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.10.7. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 12.4.11. Japan
      • 12.4.11.1. Overview
      • 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.11.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.11.4. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.11.5. Japan Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 12.4.11.6. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.11.7. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 12.4.12. South Korea
      • 12.4.12.1. Overview
      • 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.12.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.12.4. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.12.5. South Korea Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 12.4.12.6. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.12.7. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 12.4.13. Australia
      • 12.4.13.1. Overview
      • 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.13.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.13.4. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.13.5. Australia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 12.4.13.6. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.13.7. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 12.4.14. Indonesia
      • 12.4.14.1. Overview
      • 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.14.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.14.4. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.14.5. Indonesia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 12.4.14.6. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.14.7. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 12.4.15. Thailand
      • 12.4.15.1. Overview
      • 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.15.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.15.4. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.15.5. Thailand Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 12.4.15.6. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.15.7. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 12.4.16. Philippines
      • 12.4.16.1. Overview
      • 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.16.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.16.4. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.16.5. Philippines Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 12.4.16.6. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.16.7. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 12.4.17. Rest of APAC
      • 12.4.17.1. Overview
      • 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.17.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.17.4. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.17.5. Rest of APAC Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 12.4.17.6. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.17.7. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 12.5. Latin America (LATAM)
    • 12.5.1. Overview
    • 12.5.2. Diagnostic Reagents for Infectious Diseases Key Manufacturers in Latin America
    • 12.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.5.5. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.5.6. LATAM Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 12.5.7. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.5.8. LATAM Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 12.5.9. Brazil
      • 12.5.9.1. Overview
      • 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.9.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.9.4. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.9.5. Brazil Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 12.5.9.6. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.9.7. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 12.5.10. Mexico
      • 12.5.10.1. Overview
      • 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.10.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.10.4. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.10.5. Mexico Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 12.5.10.6. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.10.7. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 12.5.11. Argentina
      • 12.5.11.1. Overview
      • 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.11.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.11.4. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.11.5. Argentina Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 12.5.11.6. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.11.7. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 12.5.12. Colombia
      • 12.5.12.1. Overview
      • 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.12.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.12.4. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.12.5. Colombia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 12.5.12.6. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.12.7. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 12.5.13. Rest of LATAM
      • 12.5.13.1. Overview
      • 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.13.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.13.4. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.13.5. Rest of LATAM Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 12.5.13.6. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.13.7. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 12.6. Middle East and Africa
    • 12.6.1. Overview
    • 12.6.2. Diagnostic Reagents for Infectious Diseases Key Manufacturers in Middle East and Africa
    • 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.6.5. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.6.6. Middle East and Africa Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 12.6.7. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.6.8. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 12.6.9. Saudi Arabia
      • 12.6.9.1. Overview
      • 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.9.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.9.4. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.9.5. Saudi Arabia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 12.6.9.6. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.9.7. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 12.6.10. United Arab Emirates
      • 12.6.10.1. Overview
      • 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.10.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.10.4. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.10.5. United Arab Emirates Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 12.6.10.6. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.10.7. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 12.6.11. Israel
      • 12.6.11.1. Overview
      • 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.11.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.11.4. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.11.5. Israel Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 12.6.11.6. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.11.7. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 12.6.12. Turkey
      • 12.6.12.1. Overview
      • 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.12.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.12.4. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.12.5. Turkey Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 12.6.12.6. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.12.7. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 12.6.13. Algeria
      • 12.6.13.1. Overview
      • 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.13.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.13.4. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.13.5. Algeria Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 12.6.13.6. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.13.7. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 12.6.14. Egypt
      • 12.6.14.1. Overview
      • 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.14.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.14.4. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.14.5. Egypt Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 12.6.14.6. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.14.7. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 12.6.15. Rest of MEA
      • 12.6.15.1. Overview
      • 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.15.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.15.4. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.15.5. Rest of MEA Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 12.6.15.6. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.15.7. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

13. Key Vendor Analysis- Diagnostic Reagents for Infectious Diseases Industry

  • 13.1. Competitive Dashboard
    • 13.1.1. Competitive Benchmarking
    • 13.1.2. Competitive Positioning
  • 13.2. Company Profiles
    • 13.2.1. Abbott Laboratories
    • 13.2.2. Agilent Technologies
    • 13.2.3. Beckman Coulter
    • 13.2.4. Becton, Dickinson and Company
    • 13.2.5. Bio-Rad Laboratories
    • 13.2.6. Danaher Corporation
    • 13.2.7. DiaSorin
    • 13.2.8. Fujirebio
    • 13.2.9. Grifols
    • 13.2.10. Hologic
    • 13.2.11. Merck KGaA
    • 13.2.12. Ortho Clinical Diagnostics
    • 13.2.13. QIAGEN
    • 13.2.14. QuidelOrtho
    • 13.2.15. Randox Laboratories
    • 13.2.16. Roche Diagnostics
    • 13.2.17. Sekisui Diagnostics
    • 13.2.18. Siemens Healthineers
    • 13.2.19. Sysmex Corporation
    • 13.2.20. Thermo Fisher Scientific
    • 13.2.21. Others

14. 360 Degree Analyst View

15. Appendix

  • 15.1. Research Methodology
  • 15.2. References
  • 15.3. Abbreviations
  • 15.4. Disclaimer
  • 15.5. Contact Us